| Intermountain Hospital | |
| 303 North Allumbaugh Street, Boise, Idaho 83704 | |
| (208) 377-8400 | |
| Not Available |
| Name | Intermountain Hospital |
|---|---|
| Type | Psychiatric Hospital |
| Location | 303 North Allumbaugh Street, Boise, Idaho |
| Ownership | Proprietary |
| Emergency Services | No |
| Medicare ID (CCN) | 134002 |
| NPI Number | 1881707552 |
| Organization Name | BHC INTERMOUNTAIN HOSPITAL, INC. |
| Address | 303 Allumbaugh St, Boise, ID 83704 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 208-377-8400 |
News Archive
Researchers from the Molecular Mechanisms and Experimental Therapy in Oncology program of the Bellvitge Biomedical Research Institute and the Catalan Institute of Oncology, together with the Biodonostia Health Research Institute, among others, have published in Nutrients the results of a multicenter study that unveils a correlation between inflammatory and antioxidant diets and the risk of developing colorectal and breast cancer.
Elan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) today issued the following statement regarding the U.S. Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) as a treatment to improve walking in patients with multiple sclerosis (MS).
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has approved the expansion of BIOTRONIK's ongoing ProMRI trial. The new phase of the trial (Phase C) will study the company's ProMRI technology in implantable cardioverter-defibrillator (ICD) devices.
Researchers recently published a study assessing the risks of patients with MM to breakthrough infections after completing their vaccination schedule compared to those without any form of cancer.
Scientists at Sheffield Hallam University have discovered that simple arm exercises could help beat a crippling leg condition that affects one in twenty people over 55 in the UK.
› Verified 4 days ago
News Archive
Researchers from the Molecular Mechanisms and Experimental Therapy in Oncology program of the Bellvitge Biomedical Research Institute and the Catalan Institute of Oncology, together with the Biodonostia Health Research Institute, among others, have published in Nutrients the results of a multicenter study that unveils a correlation between inflammatory and antioxidant diets and the risk of developing colorectal and breast cancer.
Elan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) today issued the following statement regarding the U.S. Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) as a treatment to improve walking in patients with multiple sclerosis (MS).
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration has approved the expansion of BIOTRONIK's ongoing ProMRI trial. The new phase of the trial (Phase C) will study the company's ProMRI technology in implantable cardioverter-defibrillator (ICD) devices.
Researchers recently published a study assessing the risks of patients with MM to breakthrough infections after completing their vaccination schedule compared to those without any form of cancer.
Scientists at Sheffield Hallam University have discovered that simple arm exercises could help beat a crippling leg condition that affects one in twenty people over 55 in the UK.
› Verified 4 days ago
St Luke's Regional Medical Center Acute Care Hospital Location: 190 East Bannock Street, Boise, Idaho 83712 Phone: (208) 381-2222 | |
Saint Alphonsus Regional Medical Center Acute Care Hospital Location: 1055 North Curtis Road, Boise, Idaho 83706 Phone: (208) 367-2121 | |
Treasure Valley Hospital Acute Care Hospital Location: 8800 West Emerald Street, Boise, Idaho 83704 Phone: (208) 373-5000 | |
Intermountain Hospital Psychiatric Hospital Location: 303 North Allumbaugh Street, Boise, Idaho 83704 Phone: (208) 377-8400 | |
Lifeways Hospital Psychiatric Hospital Location: 8050 West Northview Street, Boise, Idaho 83704 Phone: (208) 327-0504 |